Tuberous sclerosis complex – Basic Information

Go back

Tuberous sclerosis complex is a rare genetic condition that causes non-cancerous tumors to develop in multiple organs throughout the body, affecting people in vastly different ways—some experience mild symptoms and lead independent lives, while others face significant medical challenges requiring ongoing care and support.

Understanding Tuberous Sclerosis Complex

Tuberous sclerosis complex, often shortened to TSC, is a rare genetic disorder that affects how cells grow and divide in the body. When someone has this condition, their cells don’t always know when to stop growing, which leads to the formation of tumors—abnormal growths of tissue. The good news is that these tumors are almost always non-cancerous, meaning they don’t spread throughout the body like cancer does. However, even though they’re not cancerous, these growths can still cause serious health problems depending on where they develop and how large they become.[1]

The name “tuberous sclerosis” comes from the potato-like bumps, called tubers, that can form in the brain. These tubers are actually clusters of cells that grew too quickly and ended up in slightly the wrong place or in a disorganized pattern. Think of it like a factory producing too many parts—there’s nowhere to put them all, so they pile up and create problems.[3]

TSC can affect nearly any organ in the body, but it most commonly targets the brain, skin, kidneys, heart, and lungs. Less frequently, it can also affect the eyes, liver, and other organs. The unpredictable nature of this condition means that two people with TSC—even siblings or identical twins—can have completely different experiences. One person might have such mild symptoms that they’re never diagnosed, while another might face significant medical challenges from infancy onward.[4]

How Common Is Tuberous Sclerosis Complex?

Tuberous sclerosis complex is considered a rare disease, affecting approximately one in every 6,000 to 10,000 people born. In the United States alone, there are roughly 50,000 people living with TSC, while worldwide estimates suggest about one million people have this condition. This means that at least two babies are born with TSC every day in the United States.[4]

The condition affects people equally regardless of their sex, race, or ethnicity—it doesn’t favor one group over another. TSC is present from birth, though symptoms may not appear immediately. Healthcare providers are able to diagnose about half of all TSC cases by the time a child reaches seven months of age, often because symptoms like seizures or distinctive skin changes become noticeable during this period.[3]

However, milder cases of TSC sometimes go undetected for years, or even decades. Some people aren’t diagnosed until adulthood when new symptoms develop or when medical imaging reveals brain or kidney tumors that went unnoticed earlier in life. In some instances, the condition is so mild that it never gets diagnosed at all during a person’s lifetime.[2]

What Causes Tuberous Sclerosis Complex?

TSC is caused by changes, called mutations or variants, in one of two specific genes: TSC1 or TSC2. Genes are like instruction manuals that tell our cells how to make proteins, which are the building blocks and workers of our bodies. The TSC1 gene provides instructions for making a protein called hamartin, while the TSC2 gene instructs cells to make a protein called tuberin.[1]

These two proteins work together as a team to help regulate cell growth and division. They act like a brake pedal, stopping cells from growing and dividing when they’ve reached the right size or number. Specifically, hamartin and tuberin help control another protein called mTOR, which plays a central role in telling cells to grow. When the brake system doesn’t work properly because of mutations in TSC1 or TSC2, the mTOR protein becomes overactive, and cells keep growing and dividing when they should stop. This uncontrolled growth leads to the formation of the tumors and other abnormalities seen in TSC.[1]

There are two main ways someone can develop TSC. In about two-thirds of cases, the genetic mutation happens spontaneously—it’s a random change that occurs during the early development of the embryo. In these situations, neither parent has TSC, and there’s no family history of the condition. The remaining one-third of cases are inherited, meaning a parent with TSC passes the mutated gene to their child. TSC follows an autosomal dominant pattern of inheritance, which means that a person with TSC has a 50 percent chance of passing the condition on to each of their children.[9]

⚠️ Important
For tumors to actually develop in someone with TSC, a second genetic change must occur in individual cells throughout their lifetime. A person is born with one faulty copy of either the TSC1 or TSC2 gene, but the other copy works normally and produces enough protein to keep cells mostly under control. However, when that second, normal copy gets damaged in a particular cell, that cell can no longer produce any functional hamartin or tuberin at all. Without these proteins to act as brakes, the cell grows out of control and forms a tumor. This is why TSC-related tumors can appear at different times throughout a person’s life.[9]

Risk Factors for Developing Tuberous Sclerosis Complex

Since TSC is a genetic condition that you’re born with, traditional risk factors like lifestyle choices or environmental exposures don’t increase your chances of developing it. The main risk factor is having a parent with TSC. If one parent has the condition, each of their children has a 50 percent chance of inheriting the mutated gene and developing TSC themselves.[9]

However, because most cases of TSC occur spontaneously without any family history, the majority of people with TSC come from families with no previous cases of the condition. This random occurrence means that any couple, regardless of their personal or family health history, could potentially have a child with TSC, though the chances are quite low given the rarity of the condition.[15]

Recognizing the Symptoms of Tuberous Sclerosis Complex

The symptoms of TSC vary tremendously from one person to another, depending on which organs are affected and how large or numerous the tumors become. For many people, symptoms begin appearing during infancy or childhood, but for others, symptoms may take years or even decades to develop. Some individuals experience such mild symptoms that they lead entirely normal lives with minimal medical intervention, while others require ongoing care and support for severe complications.[1]

Brain and Neurological Symptoms

The brain is one of the most commonly affected organs in TSC. Three main types of abnormal structures can develop in the brain. Cortical tubers are the tumor-like formations that give the condition its name—they appear as potato-like bumps on the outer surface of the brain. Subependymal nodules are small clusters of cells along the walls of the brain’s fluid-filled spaces, called ventricles. Sometimes these nodules grow larger and become subependymal giant cell astrocytomas, or SEGAs, which can block the flow of fluid in the brain and cause dangerous pressure buildup.[1]

Seizures are one of the most common and significant problems caused by brain tumors in TSC, affecting about 85 percent of people with the condition. Infants often develop a specific type of seizure called infantile spasms, which involve brief, repetitive muscle contractions in the head, trunk, arms, and legs. These can sometimes be mistaken for colic or stomach problems. As children grow older, they may experience other types of seizures, including focal seizures that affect only part of the brain or tonic-clonic seizures that involve the whole brain and cause loss of consciousness and body stiffening followed by jerking movements. Many people with TSC develop epilepsy that doesn’t respond well to standard medications.[5]

TSC can also cause developmental delays and intellectual disabilities, though not everyone with TSC experiences these problems. Many people with TSC have normal intelligence and live independent lives. The condition is associated with what doctors call TSC-associated neuropsychiatric disorders, or TAND, which is an umbrella term covering a wide range of cognitive, behavioral, and psychiatric issues. These can include autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), anxiety, aggression, obsessive-compulsive disorder, learning difficulties, and other challenges.[1]

Skin Changes

Skin abnormalities are extremely common in TSC, occurring in about 90 percent of people with the condition. In fact, distinctive skin changes are often the first clue that someone has TSC. One of the earliest and most characteristic signs is white or very light patches of skin called hypomelanotic macules or “ash leaf spots” because they’re often shaped like a leaf. These patches lack normal skin pigment and can appear anywhere on the body. They’re sometimes present at birth or appear during infancy.[5]

As children with TSC grow older, they may develop other skin changes. Facial angiofibromas are small, raised, reddish bumps that typically appear across the nose and cheeks, often resembling acne. These usually develop during childhood. Shagreen patches are areas of thick, raised, pebbled skin that feel like orange peel or leather, most commonly found on the lower back or neck. Small growths called ungual fibromas can develop under or around the fingernails or toenails, particularly during adolescence or adulthood.[1]

Kidney Problems

More than 80 percent of people with TSC develop some type of kidney problem at some point in their lives. The most common issue is renal angiomyolipomas—benign tumors made up of fat tissue, muscle cells, and abnormal blood vessels. These growths are usually harmless and cause no symptoms, but they can grow quite large. When they do, they may cause pain in the side or back. More seriously, the abnormal blood vessels in these tumors can be weak and prone to rupture, leading to internal bleeding that can be life-threatening. About half of people with TSC also develop fluid-filled sacs in the kidneys called renal cysts, which are generally harmless but can occasionally contribute to kidney problems.[1]

In rare cases, people with TSC can develop cancerous kidney tumors called renal cell carcinomas, though this is much less common than the benign growths. When kidney problems become severe, they can lead to kidney failure, which may require dialysis or kidney transplantation.[5]

Heart Involvement

About half of people with TSC have non-cancerous tumors in the heart called cardiac rhabdomyomas. These are most common in babies and young children and are often detected during routine prenatal ultrasounds before birth. The interesting thing about heart tumors in TSC is that they typically don’t grow larger after birth—in fact, they usually shrink over time and may disappear completely. While they’re present, though, they can cause problems by blocking blood flow through the heart or creating abnormal heart rhythms. In severe cases, they can lead to heart failure, though this is uncommon.[5]

Lung Disease

A lung condition called lymphangioleiomyomatosis, or LAM, affects some people with TSC, particularly women of childbearing age or older. LAM involves the abnormal overgrowth of smooth muscle-like tissue in the lungs, which creates cysts and damages lung tissue over time. Many people with LAM have no symptoms and don’t even know they have it, while others experience shortness of breath that gradually worsens, chest pain, or coughing. In severe cases, the lung can collapse. LAM tends to progress slowly, and symptoms may not appear until adulthood.[1]

Eye Abnormalities

TSC can cause growths in the eye, particularly on the retina—the light-sensitive tissue at the back of the eye. These benign tumors usually don’t affect vision and often don’t cause any symptoms at all. They’re typically discovered during routine eye examinations. However, in rare cases, tumors near important areas of the retina can affect sight.[5]

Preventing Tuberous Sclerosis Complex

Because TSC is a genetic condition caused by mutations that occur either randomly during early development or are inherited from a parent, there’s currently no way to prevent the condition from occurring. The spontaneous mutations that account for most cases happen by chance and aren’t influenced by anything parents do or don’t do during pregnancy or before conception.[9]

For families who already have TSC, genetic counseling can be helpful. A genetic counselor can explain the inheritance patterns, discuss the 50 percent chance of passing TSC to children, and explore family planning options. Some families may choose to use assisted reproductive technologies that allow genetic testing of embryos before pregnancy, though this is a personal decision that each family must make based on their own values and circumstances.[10]

While the condition itself can’t be prevented, early detection and intervention can help prevent or minimize many complications of TSC. This is why regular medical surveillance is so important for people with TSC—catching problems early often means they can be addressed before they become serious.[4]

How the Body Changes with Tuberous Sclerosis Complex

At its core, TSC is a disorder of cell growth regulation. Normal cells have built-in mechanisms that tell them when to grow, when to divide, and when to stop. These mechanisms ensure that organs develop to the right size and that tissues maintain themselves properly without overgrowing. In TSC, the loss of functional hamartin or tuberin proteins disrupts this careful balance, specifically by allowing the mTOR protein to remain too active.[1]

The mTOR protein is like a master switch that controls cell metabolism, growth, and division. When it’s working normally, mTOR responds to signals about nutrient availability, growth factors, and energy levels to decide whether a cell should grow or rest. In TSC, without hamartin and tuberin to keep it in check, mTOR stays in the “on” position far too often. This leads to several consequences: cells grow larger than they should, they divide more frequently than necessary, and they don’t die off when they normally would. The result is the formation of tumors—collections of too many cells that shouldn’t be there.[14]

Different types of cells respond to this uncontrolled mTOR activation in different ways, which explains why TSC causes such diverse problems throughout the body. In the brain, excessive cell growth during development leads to cortical tubers—areas where neurons and other brain cells are present in the wrong numbers or wrong locations. These disorganized areas of brain tissue can become sources of abnormal electrical activity, triggering seizures. They can also interfere with normal brain development and function, contributing to intellectual disabilities and behavioral problems in some people with TSC.[8]

In the kidneys, the overactive cell growth creates angiomyolipomas, which contain a mix of blood vessels, smooth muscle, and fat cells all growing in a disorganized fashion. The blood vessels in these tumors are particularly problematic because they’re structurally abnormal—they lack the normal layers that give blood vessels strength. This makes them prone to developing weak spots, called aneurysms, which can burst and cause dangerous bleeding.[5]

In the skin, TSC affects pigment-producing cells called melanocytes as well as other skin cells. The white ash leaf spots occur because melanocytes in those areas don’t produce normal amounts of pigment. The facial angiofibromas and other skin growths develop because skin cells proliferate excessively, creating small benign tumors. These skin changes, while sometimes cosmetically bothersome, are usually not medically dangerous, but they serve as important visible markers of the condition.[7]

The heart tumors in TSC typically form during fetal development when the heart is growing rapidly. They consist of abnormal heart muscle cells that have grown too large and in disorganized patterns. The reason these tumors often shrink after birth isn’t entirely clear, but it may be related to changes in growth signals that occur after delivery when a baby transitions from being nourished through the placenta to breathing and eating independently.[8]

In the lungs, LAM involves the proliferation of abnormal smooth muscle-like cells that gradually destroy normal lung architecture and create cysts. The progressive nature of LAM means that lung function can decline over time, making breathing increasingly difficult. The reason LAM predominantly affects women and often worsens during pregnancy or with estrogen exposure suggests that female hormones somehow interact with the underlying TSC-related cell growth problems, though the exact mechanism isn’t fully understood.[9]

⚠️ Important
Understanding that TSC is fundamentally a disorder of mTOR overactivity has been crucial for developing new treatments. Medications called mTOR inhibitors can block this overactive protein and help control tumor growth, representing a major advance in managing TSC. This is an example of how understanding what goes wrong at the molecular level in a disease can lead directly to better treatments for patients.[14]

Ongoing Clinical Trials on Tuberous sclerosis complex

  • Study on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on Basimglurant for Children, Adolescents, and Young Adults with Tuberous Sclerosis Complex-Related Seizures

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Spain
  • Long-Term Safety Study of Everolimus for Patients with Tuberous Sclerosis Complex and Refractory Seizures

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on Cannabidiol as Add-on Therapy for Seizures in Patients Aged 1-65 with Tuberous Sclerosis Complex

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on Cannabidiol Oral Solution for Infants with Tuberous Sclerosis, Dravet Syndrome, or Lennox-Gastaut Syndrome Experiencing Uncontrolled Seizures

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Italy Spain

References

https://www.ninds.nih.gov/health-information/disorders/tuberous-sclerosis-complex

https://www.mayoclinic.org/diseases-conditions/tuberous-sclerosis/symptoms-causes/syc-20365969

https://my.clevelandclinic.org/health/diseases/17586-tuberous-sclerosis

https://www.tscalliance.org/understanding-tsc/what-is-tsc/

https://www.childrenshospital.org/conditions/tuberous-sclerosis-complex-tsc

https://www.uchicagomedicine.org/conditions-services/neurology-neurosurgery/tuberous-sclerosis

https://www.ncbi.nlm.nih.gov/books/NBK538492/

https://kidshealth.org/en/parents/tuberous-sclerosis.html

https://medlineplus.gov/genetics/condition/tuberous-sclerosis-complex/

https://www.mayoclinic.org/diseases-conditions/tuberous-sclerosis/diagnosis-treatment/drc-20365971

https://my.clevelandclinic.org/health/diseases/17586-tuberous-sclerosis

https://emedicine.medscape.com/article/1177711-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC5683262/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8290505/

https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/tuberous-sclerosis

FAQ

Can tuberous sclerosis complex be cured?

There is currently no cure for tuberous sclerosis complex. However, many treatments are available to manage symptoms and complications. With proper medical care and regular monitoring throughout life, many people with TSC live full, productive lives. Research continues into new therapies that target the underlying causes of TSC at the molecular level.[2]

Will my child with TSC be able to live independently?

This varies greatly depending on the severity of the condition. Many people with TSC live completely independent lives, pursue challenging careers in fields like medicine, law, and education, and have families of their own. Others may need varying levels of support. The key factors are early diagnosis, appropriate treatments for seizures and other complications, and support for any developmental or learning challenges that may arise.[4]

How often should someone with TSC see their doctors?

People with TSC need regular lifelong monitoring because new symptoms can appear at any age. This typically involves periodic brain imaging to check for tumor growth, kidney ultrasounds to monitor for angiomyolipomas, skin examinations, and other tests depending on which organs are affected. The specific schedule is individualized based on each person’s symptoms and findings, but most people need to see specialists at least annually, with more frequent visits if problems develop.[13]

Is TSC the same in every family member who has it?

No, TSC can vary dramatically even within the same family. Siblings who both inherit TSC from a parent can have completely different symptoms—one might have severe seizures and intellectual disability while the other has only mild skin changes. Even identical twins with TSC can experience the condition very differently. This variability makes it difficult to predict how TSC will affect any individual person.[4]

Can genetic testing confirm if someone has TSC?

Genetic testing can identify mutations in the TSC1 or TSC2 genes in about 70 to 85 percent of people with TSC. However, in some cases, current testing methods don’t detect a mutation even though the person clearly has TSC based on their symptoms and other findings. Therefore, TSC is usually diagnosed based on a combination of clinical features, imaging studies, and genetic testing when available.[7]

🎯 Key takeaways

  • Tuberous sclerosis complex is a rare genetic condition affecting about 1 in 6,000 to 10,000 people, with approximately 50,000 cases in the United States.
  • The condition causes non-cancerous tumors to grow throughout the body, most commonly in the brain, skin, kidneys, heart, and lungs.
  • TSC symptoms vary dramatically from person to person—some have such mild symptoms they’re never diagnosed, while others face significant medical challenges.
  • About 85 percent of people with TSC experience seizures, making epilepsy one of the most common and serious complications of the condition.
  • Distinctive skin changes, particularly white “ash leaf” patches, often provide the first visible clue that someone has TSC.
  • Two-thirds of TSC cases occur spontaneously with no family history, while one-third are inherited from a parent with the condition.
  • Heart tumors in babies with TSC typically shrink on their own after birth and often cause no problems later in life.
  • While there’s no cure, early diagnosis and ongoing medical surveillance can help prevent complications and improve quality of life for people with TSC.